News from geno llc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 27, 2013, 08:45 ET

GeNO LLC Announces Senior Management Appointment

 GeNO LLC, a privately-held biopharmaceutical company focused on the design, development and commercialization of next-generation products to...

Jan 29, 2013, 08:00 ET

New Pre-Clinical and Clinical Data on GeNO LLC's Nitric Oxide Delivery Systems to Be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings

GeNO LLC (www.genollc.com), a privately held pharmaceutical company developing a line of innovative nitric oxide drug products, today announced...

Dec 18, 2012, 12:20 ET

GeNO LLC Announces Senior Management Appointments

Dasse named President; Gellman named Senior Vice President, Engineering  GeNO LLC, a privately held pharmaceutical company that is...

Nov 13, 2012, 08:00 ET

FDA Accepts GeNO LLC Filing of New Drug Application for GeNOsyl™ MVG-2000 Nitric Oxide Delivery System

 GeNO LLC (www.genollc.com) today announced that its New Drug Application (NDA) for GeNOsyl™ MVG-2000 Nitric Oxide Delivery System for...

Aug 21, 2012, 09:30 ET

GeNO LLC Receives Four Additional Patents for Inhaled Nitric Oxide Delivery

 GeNO LLC (www.genollc.com), a privately held pharmaceutical company developing a line of inhaled nitric oxide drug products, today announced...

Aug 14, 2012, 09:00 ET

FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)

 GeNO LLC (www.genollc.com), a privately held pharmaceutical  company developing a line of inhaled nitric oxide drug products, today...

Aug 09, 2012, 10:24 ET

GeNO LLC Receives FDA Marketing Clearance For Its Inhaled Nitric Oxide Drug Delivery Device

 GeNO LLC (www.genollc.com), a privately held pharmaceutical company developing a line of inhaled nitric oxide drug products, today announced...

Jul 31, 2012, 08:00 ET

GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery

 GeNO LLC (www.genollc.com), a privately held biotechnology company developing a line of inhaled nitric oxide drug products, today announced it...

Apr 19, 2012, 11:00 ET

New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation

 New data presented today studied the safety of the GeNO  system for delivering inhaled nitric oxide (NO) to patients being evaluated for...

Apr 11, 2012, 09:00 ET

New Data on GeNO LLC Nitric Oxide Delivery System to be Presented at ISHLT Conference Next Week

 GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced that data on the NITROSYL...

Jan 31, 2012, 09:19 ET

GeNO LLC Receives New Patent for Nitric Oxide Delivery Technology

   GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced it has been...

Jan 19, 2012, 09:21 ET

GeNO LLC Makes Significant Additions to Management Team to Increase Capability and Talent

 GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced the hiring of four new senior...

Dec 15, 2011, 09:45 ET

GeNO LLC Receives Two New Patents for Nitric Oxide Delivery Technology

 GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced it has been awarded two new US...

Aug 23, 2011, 09:00 ET

GeNO LLC Receives Federal Grant To Advance Studies of Inhaled Nitric Oxide Product for the Treatment of Chronic Pulmonary Diseases

GeNO LLC, (www.genollc.com) a privately held, advanced development-stage technology company, today announced that it has received a new federal...

Jun 09, 2011, 09:57 ET

GeNO LLC Announces New Patent for Nitric Oxide Delivery System

GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced it has been awarded a new patent for...

Apr 05, 2011, 09:00 ET

GeNO LLC Receives Additional Patent for Inhaled NITROSYL™ Nitric Oxide Product

GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced that it received a sixth patent on its...

Mar 22, 2011, 10:13 ET

GeNO LLC Initiates Study of Inhaled NITROSYL™ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients

GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced commencement of  the PHiano...

Dec 08, 2010, 10:31 ET

GeNO LLC Initiates Phase 2 Trial For Nitric Oxide Delivery System

GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, today announced commencement of the Phase 2 clinical...

Dec 02, 2010, 11:38 ET

FDA Clears GeNO LLC's Investigational New Drug Application for Clinical Trials With Its NITROSYL™ Inhaled Nitric Oxide System

GeNO LLC (www.genollc.com), a privately held, advanced development-stage technology company, announced today that the U.S. Food and Drug...

Nov 02, 2010, 10:12 ET

GeNO LLC Submits Investigational New Drug Application for Its NITROsyl™ Inhaled Nitric Oxide System to Treat Chronic Pulmonary Hypertension

GeNO LLC (www.genollc.com) a privately held, advanced development-stage technology company announced today that it has submitted an Investigational...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge